Breaking News Instant updates and real-time market news.

ACN

Accenture

$117.46

1.46 (1.26%)

, MCK

McKesson

$165.33

-0.49 (-0.30%)

07:36
10/11/16
10/11
07:36
10/11/16
07:36

Apigee to hold a conference

Adapt or Die Conference is being held in New York on October 11.

ACN

Accenture

$117.46

1.46 (1.26%)

MCK

McKesson

$165.33

-0.49 (-0.30%)

PBI

Pitney Bowes

$17.62

0.04 (0.23%)

GOOG

Alphabet

$785.94

10.86 (1.40%)

TRI

Thomson Reuters

$40.75

0.25 (0.62%)

APIC

Acquired by Google

$17.37

-0.01 (-0.06%)

  • 11

    Oct

  • 23

    Oct

  • 27

    Oct

  • 27

    Oct

  • 01

    Nov

  • 06

    Nov

  • 08

    Nov

  • 10

    Nov

  • 17

    Nov

  • 15

    Jan

ACN Accenture
$117.46

1.46 (1.26%)

09/26/16
SOCG
09/26/16
UPGRADE
SOCG
Buy
Accenture upgraded to Buy from Hold at Societe Generale
09/08/16
WEDB
09/08/16
INITIATION
Target $125
WEDB
Outperform
Accenture initiated with an Outperform at Wedbush
Wedbush analyst Moshe Katri initiated Accenture with an Outperform and named it a Top Pick in IT Services with a $125 price target. The analyst expects Accenture to continue to benefit from recent SMAC investment as well as from its aggressive global delivery model which will likely provide incremental growth and scale. Katri recommends owning the stock post Q4 earnings on September 29, which he expects cautious guidance commentary but notes management has a long, consistent track record of returning cash to shareholders.
07/12/16
PACS
07/12/16
INITIATION
PACS
Overweight
Accenture initiated at Pacific Crest
As noted earlier, Pacific Crest initiated coverage of Accenture with an Overweight rating. The firm expects the company's revenue to continue to grow going forward, driven partly by the quality of its global delivery model and increased demand in the wake of technological upgrades. Target $129.
07/12/16
PACS
07/12/16
INITIATION
Target $129
PACS
Overweight
Accenture initiated with an Overweight at Pacific Crest
Pacific Crest analyst Arvind Ramnani started Accenture with an Overweight rating and $129 price target.
MCK McKesson
$165.33

-0.49 (-0.30%)

09/16/16
GSCO
09/16/16
DOWNGRADE
Target $189
GSCO
Neutral
McKesson downgraded to Neutral from Buy at Goldman
As previously reported, Goldman downgraded McKesson to Neutral from Buy and lowered its price target to $189 from $210. Analyst Robert Jones said softer brand price inflation presents additional risk to earnings, combined with headwinds from generics, M&A related contract losses, and foreign exchange. The analyst does not foresee any compelling earnings drivers outside of unknown M&A or capital deployment to push shares higher.
09/27/16
COWN
09/27/16
NO CHANGE
COWN
Market Perform
Drag on drug distributors from brand inflation worries overdone, says Cowen
Cowen analyst Charles Rhyee said he views recent concerns over moderating brand inflation and their potential impact on drug distributors as "somewhat overblown," considering that he sees the issue as a 1%-2% headwind to adjusted EPS for the group. Additionally, Rhyee expects brand inflation to revert to normal levels once the current political rhetoric dies down. The analyst trimmed his price target on AmerisourceBergen (ABC) to $88 from $90, on Cardinal Health (CAH) to $86 from $89 and on McKesson (MCK) to $188 from $200 and keeps a Market Perform rating on all three stocks.
09/19/16
MSCO
09/19/16
NO CHANGE
MSCO
Drug Distributor price targets lowered at Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser sees downside to December quarter earnings for distributors due to difficult year-over-year pricing comps. The analyst nows sees branded pricie moderation down 300 bps year-over-year versus 100bps previously as some drug manufacturers may be looking for moderating pricing practices following the Epipen controversy. As a result, Goldwasswer lowered estimates to reflect moderation in branded inflation and reduced price targets on McKesson (MCK) to $185 from $221, AmerisourceBergen (ABC) to $84 from $89, and Cardinal Health (CAH) to $82 from $91.
10/05/16
UBSW
10/05/16
INITIATION
Target $182
UBSW
Neutral
McKesson initiated with a Neutral at UBS
Target $182.
PBI Pitney Bowes
$17.62

0.04 (0.23%)

02/03/16
BMUR
02/03/16
NO CHANGE
Target $25
BMUR
Buy
Pitney Bowes shares 'absolutely oversold,' says Brean Capital
Brean Capital analyst Ananda Baruah said shares of Pitney Bowes, which are down roughly 30% since its earnings miss, are "absolutely oversold." The analyst said all of the incremental earnings dynamics the company guided to at its analyst day are manifesting as anticipated. Baruah said the two most important aspects of the business, the core metering business and eCommerce, are actually outperforming. Brean Capital reiterated its Buy rating and lowered its price target to $25 from $30 on Pitney Bowes shares.
GOOG Alphabet
$785.94

10.86 (1.40%)

09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
10/06/16
SBSH
10/06/16
NO CHANGE
Target $89
SBSH
Buy
Citi says Salesforce buying Twitter 'nearly impossible' above $28/share
Citi analyst Walter Pritchard believes a Salesforce (CRM) acquisition of Twitter (TWTR) is possible financially but that such a deal would put "significant constraints" on the company for the next three-plus years. The analyst sees "very little reason" for Salesforce to own Twitter and feels the acquisition "would pose a difficult decision" for CEO Marc Benioff and the board. Salesforce closed yesterday down 6%, or $4.21, to $68.42. Recode reported last night that the company is likely the only bidder left for Twitter after Disney (DIS) and Alphabet (GOOG) opted not to pursue a deal while Apple (AAPL) is unlikely. Twitter in pre-market trading is down 14% to $21.50. In order for Salesforce to avoid a shareholder vote, it would have to borrow $7.5B to fund the transaction if Twitter were valued at $20B, or $27.50-$28 per share, Pritchard tells investors in a research note. This is a level that likely constrains the company with little additional borrowing capacity for other deals, the analyst contends. He thinks the deal is "nearly impossible to do" for Salesforce should the bidding for Twitter go above $20B or $28 per share. Pritchard has a Buy rating on Salesforce with an $89 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Alphabet, Facebook can meet Street estimates, says Wells Fargo
Wells Fargo says that investors are concerned about the ability of Facebook (FB) and Google (GOOG,GOOGL) to meet Street estimates because forecasts continue to indicate that TV's ad share will be relatively stable over the next two years. But Wells says that Facebook and Google will continue to gain share from "non-TV media" and could see increased revenue from "non-advertising marketing services" such as sponsorships and public relations. Wells keeps Outperform ratings on both stocks.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TRI Thomson Reuters
$40.75

0.25 (0.62%)

01/07/16
BOFA
01/07/16
DOWNGRADE
BOFA
Neutral
Thomson Reuters downgraded to Neutral from Buy at BofA/Merrill
08/25/16
MACQ
08/25/16
INITIATION
MACQ
Neutral
Thomson Reuters initiated with a Neutral at Macquarie
06/27/16
TDSI
06/27/16
DOWNGRADE
TDSI
Hold
Thomson Reuters downgraded to Hold from Buy at TD Securities
TD Securities analyst Vince Valentini downgraded Thomson Reuters to Hold citing Brexit and macro uncertainty.
01/07/16
01/07/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 1st Constitution Bancorp (FCCY) downgraded to Market Perform at Raymond James... Alaska Air (ALK) downgraded to Neutral from Outperform at Credit Suisse... Alexion (ALXN) downgraded to Neutral from Buy at BTIG... Anadarko (APC) downgraded to Hold from Buy at Deutsche Bank... Apple Hospitality REIT (APLE) downgraded to Neutral from Outperform at Baird... Aqua America (WTR) downgraded to Neutral from Buy at Ladenburg... ArcBest (ARCB) downgraded to Equal Weight from Overweight at Stephens... Ashford Hospitality Prime (AHP) downgraded to Underperform from Neutral at Baird... Broadcom (BRCM) downgraded to Market Perform from Outperform at Bernstein... Brown & Brown (BRO) downgraded to Neutral from Buy at SunTrust... Caladrius (CLBS) downgraded to Hold from Buy at Maxim... Capital One (COF) downgraded to Hold from Buy at Deutsche Bank... DDR Corp. (DDR) downgraded to Neutral from Outperform at Baird... Everyday Health (EVDY) downgraded on salesforce issues at Stifel... Expeditors (EXPD) downgraded to Sell from Neutral at UBS... First Community (FCCO) downgraded to Market Perform from Outperform at Raymond James... Genesee & Wyoming (GWR) downgraded to Sector Perform from Outperform at RBC Capital... HP Inc. (HPQ) downgraded to Market Perform from Outperform at Wells Fargo... Heartland Express (HTLD) downgraded to Underperform from Sector Perform at RBC Capital... Highwoods Properties (HIW) downgraded to Neutral from Outperform at Baird... Horizon Bancorp (HBNC) downgraded to Hold from Buy at Sandler O'Neill... Hubbell (HUBB) downgraded to Neutral from Overweight at JPMorgan... Illumina (ILMN) downgraded to Market Perform from Outperform at Wells Fargo... Kite Realty Trust (KRG) downgraded to Neutral from Outperform at Baird... Mondelez (MDLZ) downgraded to Hold from Buy at Deutsche Bank... Moody's (MCO) downgraded to Neutral from Overweight at Piper Jaffray... Morgan Stanley says Nordstrom (JWN) not immune from industry headwinds, cuts to sell... National Retail Properties (NNN) downgraded to Market Perform from Outperform at Raymond James... Navios Maritime (NM) downgraded to Sell on cash burn at Stifel... Newmont Mining (NEM) downgraded to Sector Perform from Outperform at RBC Capital... Nordstrom (JWN) downgraded to Underweight from Equal Weight at Morgan Stanley... Old Dominion (ODFL) downgraded to Sector Perform from Outperform at RBC Capital... Paychex (PAYX) downgraded to Underperform from Neutral at BofA/Merrill... PerkinElmer (PKI) downgraded to Market Perform from Outperform at Cowen... Piedmont Office Realty (PDM) downgraded to Neutral from Outperform at Baird... Post Properties (PPS) downgraded to Market Perform from Outperform at Raymond James... Public Storage (PSA) downgraded to Market Perform from Outperform at Raymond James... Rush Enterprises (RUSHA) downgraded to Sector Perform from Outperform at RBC Capital... Ryder (R) downgraded to Sector Perform from Outperform at RBC Capital... Saia, Inc. (SAIA) downgraded to Equal Weight from Overweight at Stephens... Scorpio Bulkers (SALT) downgraded to Hold from Buy at Stifel... Spirit Realty (SRC) downgraded to Neutral from Outperform at Baird... Star Bulk Carriers (SBLK) downgraded to Hold from Buy at Stifel... Stryker (SYK) downgraded to Market Perform from Outperform at Northland... Swift Transport (SWFT) downgraded to Sector Perform from Outperform at RBC Capital... Team (TISI) downgraded to Hold from Buy at BB&T... Terreno Realty (TRNO) downgraded to Neutral from Outperform at Baird... Thomson Reuters (TRI) downgraded to Neutral from Buy at BofA/Merrill... UBS (UBS) downgraded to Equal Weight from Overweight at Barclays... WebMD (WBMD) downgraded to Hold from Buy at Stifel... Whiting USA Trust II (WHZ) downgraded to Underperform at Raymond James... Zimmer Biomet (ZBH) downgraded to Market Perform from Outperform at Northland.
APIC Acquired by Google
$17.37

-0.01 (-0.06%)

09/15/16
ROTH
09/15/16
DOWNGRADE
Target $17.4
ROTH
Neutral
Apigee downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Richard Baldry downgraded Apigee (APIC) to Neutral from Buy citing its recently announced deal to be acquired by Google (GOOG; GOOGL) for $17.40 in an all-cash deal. The analyst believes the deal will be consummated as announced.
09/15/16
PACS
09/15/16
DOWNGRADE
PACS
Sector Weight
Apigee downgraded to Sector Weight from Overweight at Pacific Crest
Pacific Crest analyst Ben McFadden downgraded Apigee (APIC) to Sector Weight citing the acquisition by Google (GOOG, GOOGL). The analyst views a higher bid as unlikely.
09/15/16
FBCO
09/15/16
DOWNGRADE
Target $17.4
FBCO
Neutral
Apigee downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Michael Nemeroff downgraded Apigee (APIC) to Neutral to reflect Google's (GOOGL) acquisition of the company for $17.40 per share.
10/10/16
JMPS
10/10/16
DOWNGRADE
JMPS
Market Perform
Apigee downgraded to Market Perform from Outperform at JMP Securities
JMP Securities downgraded Apigee (APIC) to Neutral to reflect Google's (GOOGL) acquisition of the company for $17.40 per share.

TODAY'S FREE FLY STORIES

CMG

Chipotle

$471.76

2.97 (0.63%)

05:43
04/26/17
04/26
05:43
04/26/17
05:43
Downgrade
Chipotle rating change  »

Chipotle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$76.65

0.82 (1.08%)

05:43
04/26/17
04/26
05:43
04/26/17
05:43
Downgrade
Shopify rating change  »

Shopify downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 24

    May

ALGT

Allegiant Travel

$163.85

-1.2 (-0.73%)

05:40
04/26/17
04/26
05:40
04/26/17
05:40
Downgrade
Allegiant Travel rating change  »

Allegiant Travel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DYN

Dynegy

$6.19

-0.11 (-1.75%)

05:37
04/26/17
04/26
05:37
04/26/17
05:37
Upgrade
Dynegy rating change  »

Dynegy upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

RSPP

RSP Permian

$38.69

1.32 (3.53%)

05:33
04/26/17
04/26
05:33
04/26/17
05:33
Initiation
RSP Permian initiated  »

RSP Permian reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

CPE

Callon Petroleum

$12.24

0.39 (3.29%)

05:32
04/26/17
04/26
05:32
04/26/17
05:32
Initiation
Callon Petroleum initiated  »

Callon Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

LOGI

Logitech

$31.79

0.99 (3.21%)

05:32
04/26/17
04/26
05:32
04/26/17
05:32
Earnings
Logitech backs FY18 outlook of high single-digit retail sales growth »

Logitech confirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

FSNN

Fusion Telecommunications

$1.43

0.01 (0.70%)

05:31
04/26/17
04/26
05:31
04/26/17
05:31
Initiation
Fusion Telecommunications initiated  »

Fusion Telecommunications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

LOGI

Logitech

$31.79

0.99 (3.21%)

05:30
04/26/17
04/26
05:30
04/26/17
05:30
Earnings
Logitech reports Q4 EPS 15c, consensus 17c »

Reports Q4 revenue $496M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SKYAY

Sky

$50.26

0.05 (0.10%)

05:29
04/26/17
04/26
05:29
04/26/17
05:29
Upgrade
Sky rating change  »

Sky upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.56

0.91 (1.70%)

05:26
04/26/17
04/26
05:26
04/26/17
05:26
Hot Stocks
Wells Fargo issues statement in response to CA State Treasurer John Chiang »

"Notwithstanding the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

KLRE

KLR Energy Acquisition

$10.55

0.1384 (1.33%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
KLR Energy Acquisition to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Ionis Pharmaceuticals management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 24

    May

ADMS

Adamas Pharmaceuticals

$16.36

0.51 (3.22%)

, AVXS

AveXis

$78.74

-0.44 (-0.56%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
American Academy of Neurology »

69th Annual Meeting of…

ADMS

Adamas Pharmaceuticals

$16.36

0.51 (3.22%)

AVXS

AveXis

$78.74

-0.44 (-0.56%)

CATB

Catabasis Pharmaceuticals

$1.48

-0.02 (-1.33%)

MNOV

MediciNova

$5.57

0.14 (2.58%)

IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

FLKS

Flex Pharma

$3.07

0.01 (0.33%)

TGTX

TG Therapeutics

$12.00

1.6 (15.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 24

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 24

    Aug

ATEC

Alphatec

$1.98

0.02 (1.02%)

, CAE

CAE

$15.39

0.01 (0.07%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
American Association of Neurological Surgeons to hold annual meeting »

2017 AANS Annual…

ATEC

Alphatec

$1.98

0.02 (1.02%)

CAE

CAE

$15.39

0.01 (0.07%)

EDGE

Edge Therapeutics

$10.72

1.07 (11.09%)

MDT

Medtronic

$81.76

1.11 (1.38%)

NUVA

NuVasive

$76.94

0.59 (0.77%)

SYK

Stryker

$135.59

1.14 (0.85%)

VRTX

Vertex

$117.27

-0.39 (-0.33%)

SYNA

Synaptics

$52.54

0.84 (1.62%)

NVIV

InVivo Therapeutics

$4.00

0.05 (1.27%)

LMAT

LeMaitre

$25.63

0.17 (0.67%)

MZOR

Mazor Robotics

$34.74

0.98 (2.90%)

OFIX

Orthofix

$39.28

0.19 (0.49%)

SSNLF

Samsung

SIEGY

Siemens

$72.70

0.615 (0.85%)

SNE

Sony

$33.65

-0.17 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 03

    May

  • 18

    May

  • 24

    May

  • 25

    May

  • 31

    May

  • 06

    Jun

ABUS

Arbutus Biopharma

$3.35

0.05 (1.52%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Arbutus Biopharma management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SXL

Sunoco Logistics

$24.35

0.64 (2.70%)

, ETP

Energy Transfer Partners

$36.42

0.98 (2.77%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Energy Transfer Partners to host special shareholder meeting »

Special Shareholder…

SXL

Sunoco Logistics

$24.35

0.64 (2.70%)

ETP

Energy Transfer Partners

$36.42

0.98 (2.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    May

TIG

TiGenix

$16.36

0.08 (0.49%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
TiGenix management to meet with Canaccord »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

MTSI

MACOM

$53.84

-0.17 (-0.31%)

, SBGI

Sinclair Broadcast

$39.30

-0.15 (-0.38%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
National Association of Broadcasters to hold a conference »

NAB Show 2017 is being…

MTSI

MACOM

$53.84

-0.17 (-0.31%)

SBGI

Sinclair Broadcast

$39.30

-0.15 (-0.38%)

NXST

Nexstar

$68.90

0.3 (0.44%)

TRCO

Tribune Media

$36.55

-0.08 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 09

    May

  • 22

    May

  • 23

    May

DWCH

Datawatch

$9.40

0.1 (1.08%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Datawatch management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/17
04/26
04:55
04/26/17
04:55
General news
Breaking General news story  »

Week of 4/21 MBA Mortgage…

04:55
04/26/17
04/26
04:55
04/26/17
04:55
General news
Breaking General news story  »

Week of 4/21 EIA…

INFO

IHS Markit

$43.76

-0.05 (-0.11%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
IHS Markit to hold an investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

KURA

Kura Oncology

$11.20

0.75 (7.18%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Kura Oncology management to meet with JMP Securities »

Meeting to be held on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RGLS

Regulus

$1.45

0.05 (3.57%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Regulus management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.